Supplementary Table S1: summary of 454 BP pathways, 67 CC pathways, 40 MF pathways significantly enriched. 
ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
BP	GO:0002443	leukocyte mediated immunity	14/52	457/18800	1.57E-11	2.53E-08	1.53E-08	CX3CR1/HLA-DMB/FCER1G/CXCL6/ITGB2/AZGP1/PTPRC/HLA-DMA/RAC2/TYROBP/C3/HLA-DQB1/HLA-DRA/IGHM	14
BP	GO:0019730	antimicrobial humoral response	9/52	122/18800	4.40E-11	2.60E-08	1.58E-08	HRG/LTF/CXCL6/LYZ/REG1A/CXCL9/DEFB1/CXCL14/IGHM	9
BP	GO:0006959	humoral immune response	12/52	317/18800	4.85E-11	2.60E-08	1.58E-08	HRG/LTF/CXCL6/PTPRC/C3/LYZ/HLA-DQB1/REG1A/CXCL9/DEFB1/CXCL14/IGHM	12
BP	GO:0019886	antigen processing and presentation of exogenous peptide antigen via MHC class II	6/52	30/18800	1.88E-10	7.56E-08	4.58E-08	HLA-DMB/FCER1G/CTSS/HLA-DMA/HLA-DQB1/HLA-DRA	6
BP	GO:0048002	antigen processing and presentation of peptide antigen	7/52	63/18800	4.00E-10	9.70E-08	5.88E-08	HLA-DMB/FCER1G/CTSS/AZGP1/HLA-DMA/HLA-DQB1/HLA-DRA	7
BP	GO:0007159	leukocyte cell-cell adhesion	12/52	381/18800	4.02E-10	9.70E-08	5.88E-08	CX3CR1/HLA-DMB/ITGB2/ARG2/PTPRC/HLA-DMA/CCL5/RAC2/HLA-DQB1/VCAM1/HLA-DRA/S100A8	12
BP	GO:0002495	antigen processing and presentation of peptide antigen via MHC class II	6/52	34/18800	4.21E-10	9.70E-08	5.88E-08	HLA-DMB/FCER1G/CTSS/HLA-DMA/HLA-DQB1/HLA-DRA	6
BP	GO:0019882	antigen processing and presentation	8/52	107/18800	5.16E-10	1.04E-07	6.30E-08	PSMB8/HLA-DMB/FCER1G/CTSS/AZGP1/HLA-DMA/HLA-DQB1/HLA-DRA	8
BP	GO:0002504	antigen processing and presentation of peptide or polysaccharide antigen via MHC class II	6/52	36/18800	6.08E-10	1.09E-07	6.60E-08	HLA-DMB/FCER1G/CTSS/HLA-DMA/HLA-DQB1/HLA-DRA	6
BP	GO:0060326	cell chemotaxis	11/52	315/18800	8.05E-10	1.26E-07	7.62E-08	CX3CR1/HRG/FCER1G/CXCL6/ITGB2/CCL5/RAC2/VCAM1/CXCL9/CXCL14/S100A8	11
BP	GO:0002478	antigen processing and presentation of exogenous peptide antigen	6/52	38/18800	8.58E-10	1.26E-07	7.62E-08	HLA-DMB/FCER1G/CTSS/HLA-DMA/HLA-DQB1/HLA-DRA	6
BP	GO:0032496	response to lipopolysaccharide	11/52	333/18800	1.44E-09	1.94E-07	1.18E-07	CX3CR1/LTF/CXCL6/IL10RA/CCL5/HCK/VCAM1/FOS/CXCL9/CD14/S100A8	11
BP	GO:0001906	cell killing	9/52	185/18800	1.82E-09	2.25E-07	1.37E-07	CX3CR1/LTF/CXCL6/AZGP1/PTPRC/TYROBP/C3/LYZ/HLA-DRA	9
BP	GO:0061844	antimicrobial humoral immune response mediated by antimicrobial peptide	7/52	79/18800	2.03E-09	2.33E-07	1.41E-07	HRG/LTF/CXCL6/REG1A/CXCL9/DEFB1/CXCL14	7
BP	GO:0002237	response to molecule of bacterial origin	11/52	354/18800	2.74E-09	2.94E-07	1.78E-07	CX3CR1/LTF/CXCL6/IL10RA/CCL5/HCK/VCAM1/FOS/CXCL9/CD14/S100A8	11
BP	GO:0019884	antigen processing and presentation of exogenous antigen	6/52	47/18800	3.27E-09	3.30E-07	2.00E-07	HLA-DMB/FCER1G/CTSS/HLA-DMA/HLA-DQB1/HLA-DRA	6
BP	GO:0002886	regulation of myeloid leukocyte mediated immunity	6/52	59/18800	1.34E-08	1.27E-06	7.70E-07	CX3CR1/CXCL6/ITGB2/RAC2/TYROBP/C3	6
BP	GO:0002703	regulation of leukocyte mediated immunity	9/52	236/18800	1.53E-08	1.37E-06	8.28E-07	CX3CR1/CXCL6/ITGB2/AZGP1/PTPRC/RAC2/TYROBP/C3/HLA-DRA	9
BP	GO:0030593	neutrophil chemotaxis	7/52	106/18800	1.61E-08	1.37E-06	8.28E-07	FCER1G/CXCL6/ITGB2/CCL5/RAC2/CXCL9/S100A8	7
BP	GO:0002697	regulation of immune effector process	10/52	353/18800	3.77E-08	3.03E-06	1.84E-06	CX3CR1/HLA-DMB/CXCL6/ITGB2/AZGP1/PTPRC/RAC2/TYROBP/C3/HLA-DRA	10
BP	GO:0042742	defense response to bacterium	10/52	364/18800	5.02E-08	3.85E-06	2.34E-06	GBP2/LTF/FCER1G/CXCL6/ARG2/LYZ/ISG15/DEFB1/S100A8/IGHM	10
BP	GO:0071621	granulocyte chemotaxis	7/52	128/18800	5.96E-08	4.18E-06	2.53E-06	FCER1G/CXCL6/ITGB2/CCL5/RAC2/CXCL9/S100A8	7
BP	GO:1990266	neutrophil migration	7/52	128/18800	5.96E-08	4.18E-06	2.53E-06	FCER1G/CXCL6/ITGB2/CCL5/RAC2/CXCL9/S100A8	7
BP	GO:0050900	leukocyte migration	10/52	384/18800	8.29E-08	5.51E-06	3.34E-06	CX3CR1/FCER1G/CXCL6/ITGB2/CCL5/HCK/RAC2/VCAM1/CXCL9/S100A8	10
BP	GO:0042119	neutrophil activation	5/52	41/18800	9.24E-08	5.51E-06	3.34E-06	FCER1G/CXCL6/ITGB2/CCL5/TYROBP	5
BP	GO:0002399	MHC class II protein complex assembly	4/52	16/18800	9.24E-08	5.51E-06	3.34E-06	HLA-DMB/HLA-DMA/HLA-DQB1/HLA-DRA	4
BP	GO:0002503	peptide antigen assembly with MHC class II protein complex	4/52	16/18800	9.24E-08	5.51E-06	3.34E-06	HLA-DMB/HLA-DMA/HLA-DQB1/HLA-DRA	4
BP	GO:0001910	regulation of leukocyte mediated cytotoxicity	6/52	85/18800	1.23E-07	7.08E-06	4.29E-06	CX3CR1/CXCL6/AZGP1/PTPRC/TYROBP/HLA-DRA	6
BP	GO:0016064	immunoglobulin mediated immune response	8/52	216/18800	1.30E-07	7.22E-06	4.38E-06	HLA-DMB/FCER1G/PTPRC/HLA-DMA/C3/HLA-DQB1/HLA-DRA/IGHM	8
BP	GO:0019724	B cell mediated immunity	8/52	219/18800	1.45E-07	7.76E-06	4.71E-06	HLA-DMB/FCER1G/PTPRC/HLA-DMA/C3/HLA-DQB1/HLA-DRA/IGHM	8
BP	GO:0006909	phagocytosis	9/52	310/18800	1.58E-07	8.23E-06	4.99E-06	FCER1G/ITGB2/PTPRC/HCK/RAC2/TYROBP/C3/CD14/IGHM	9
BP	GO:0036230	granulocyte activation	5/52	47/18800	1.87E-07	9.40E-06	5.70E-06	FCER1G/CXCL6/ITGB2/CCL5/TYROBP	5
BP	GO:0002696	positive regulation of leukocyte activation	10/52	421/18800	1.95E-07	9.50E-06	5.76E-06	HLA-DMB/ITGB2/PTPRC/HLA-DMA/CCL5/TYROBP/HLA-DQB1/VCAM1/HLA-DRA/IGHM	10
BP	GO:0097529	myeloid leukocyte migration	8/52	229/18800	2.03E-07	9.64E-06	5.85E-06	CX3CR1/FCER1G/CXCL6/ITGB2/CCL5/RAC2/CXCL9/S100A8	8
BP	GO:0097530	granulocyte migration	7/52	154/18800	2.12E-07	9.76E-06	5.92E-06	FCER1G/CXCL6/ITGB2/CCL5/RAC2/CXCL9/S100A8	7
BP	GO:0002274	myeloid leukocyte activation	8/52	232/18800	2.25E-07	1.01E-05	6.10E-06	CX3CR1/FCER1G/CXCL6/ITGB2/PTPRC/CCL5/RAC2/TYROBP	8
BP	GO:0002396	MHC protein complex assembly	4/52	20/18800	2.44E-07	1.03E-05	6.27E-06	HLA-DMB/HLA-DMA/HLA-DQB1/HLA-DRA	4
BP	GO:0002501	peptide antigen assembly with MHC protein complex	4/52	20/18800	2.44E-07	1.03E-05	6.27E-06	HLA-DMB/HLA-DMA/HLA-DQB1/HLA-DRA	4
BP	GO:0030595	leukocyte chemotaxis	8/52	236/18800	2.56E-07	1.06E-05	6.41E-06	CX3CR1/FCER1G/CXCL6/ITGB2/CCL5/RAC2/CXCL9/S100A8	8
BP	GO:0050867	positive regulation of cell activation	10/52	436/18800	2.69E-07	1.08E-05	6.57E-06	HLA-DMB/ITGB2/PTPRC/HLA-DMA/CCL5/TYROBP/HLA-DQB1/VCAM1/HLA-DRA/IGHM	10
BP	GO:0031341	regulation of cell killing	6/52	100/18800	3.25E-07	1.28E-05	7.75E-06	CX3CR1/CXCL6/AZGP1/PTPRC/TYROBP/HLA-DRA	6
BP	GO:1903039	positive regulation of leukocyte cell-cell adhesion	8/52	245/18800	3.41E-07	1.31E-05	7.92E-06	HLA-DMB/ITGB2/PTPRC/HLA-DMA/CCL5/HLA-DQB1/VCAM1/HLA-DRA	8
BP	GO:0050863	regulation of T cell activation	9/52	342/18800	3.63E-07	1.36E-05	8.24E-06	HLA-DMB/ARG2/PTPRC/HLA-DMA/CCL5/RAC2/HLA-DQB1/VCAM1/HLA-DRA	9
BP	GO:0002699	positive regulation of immune effector process	8/52	248/18800	3.73E-07	1.36E-05	8.27E-06	HLA-DMB/ITGB2/AZGP1/PTPRC/RAC2/TYROBP/C3/HLA-DRA	8
BP	GO:1903037	regulation of leukocyte cell-cell adhesion	9/52	344/18800	3.81E-07	1.36E-05	8.27E-06	HLA-DMB/ITGB2/ARG2/PTPRC/HLA-DMA/CCL5/HLA-DQB1/VCAM1/HLA-DRA	9
BP	GO:0002444	myeloid leukocyte mediated immunity	6/52	104/18800	4.10E-07	1.44E-05	8.71E-06	CX3CR1/CXCL6/ITGB2/RAC2/TYROBP/C3	6
BP	GO:0045071	negative regulation of viral genome replication	5/52	57/18800	4.99E-07	1.71E-05	1.04E-05	LTF/ISG20/IFITM1/CCL5/ISG15	5
BP	GO:0002449	lymphocyte mediated immunity	9/52	365/18800	6.26E-07	2.10E-05	1.27E-05	HLA-DMB/FCER1G/AZGP1/PTPRC/HLA-DMA/C3/HLA-DQB1/HLA-DRA/IGHM	9
BP	GO:0032640	tumor necrosis factor production	7/52	182/18800	6.58E-07	2.12E-05	1.28E-05	CX3CR1/LTF/CYBB/ARG2/PTPRC/TYROBP/CD14	7
BP	GO:0032680	regulation of tumor necrosis factor production	7/52	182/18800	6.58E-07	2.12E-05	1.28E-05	CX3CR1/LTF/CYBB/ARG2/PTPRC/TYROBP/CD14	7
BP	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	9/52	370/18800	7.01E-07	2.21E-05	1.34E-05	HLA-DMB/FCER1G/AZGP1/PTPRC/HLA-DMA/C3/HLA-DQB1/HLA-DRA/IGHM	9
BP	GO:0051251	positive regulation of lymphocyte activation	9/52	371/18800	7.17E-07	2.21E-05	1.34E-05	HLA-DMB/PTPRC/HLA-DMA/CCL5/TYROBP/HLA-DQB1/VCAM1/HLA-DRA/IGHM	9
BP	GO:0019221	cytokine-mediated signaling pathway	10/52	486/18800	7.26E-07	2.21E-05	1.34E-05	CX3CR1/FCER1G/CXCL6/IL10RA/IFITM1/PTPRC/CCL5/HCK/ISG15/CXCL9	10
BP	GO:0071706	tumor necrosis factor superfamily cytokine production	7/52	187/18800	7.89E-07	2.31E-05	1.40E-05	CX3CR1/LTF/CYBB/ARG2/PTPRC/TYROBP/CD14	7
BP	GO:1903555	regulation of tumor necrosis factor superfamily cytokine production	7/52	187/18800	7.89E-07	2.31E-05	1.40E-05	CX3CR1/LTF/CYBB/ARG2/PTPRC/TYROBP/CD14	7
BP	GO:0002366	leukocyte activation involved in immune response	8/52	285/18800	1.07E-06	3.07E-05	1.86E-05	CX3CR1/HLA-DMB/FCER1G/ITGB2/PTPRC/RAC2/TYROBP/HLA-DRA	8
BP	GO:0002263	cell activation involved in immune response	8/52	289/18800	1.18E-06	3.35E-05	2.03E-05	CX3CR1/HLA-DMB/FCER1G/ITGB2/PTPRC/RAC2/TYROBP/HLA-DRA	8
BP	GO:0022409	positive regulation of cell-cell adhesion	8/52	291/18800	1.25E-06	3.47E-05	2.10E-05	HLA-DMB/ITGB2/PTPRC/HLA-DMA/CCL5/HLA-DQB1/VCAM1/HLA-DRA	8
BP	GO:0001909	leukocyte mediated cytotoxicity	6/52	131/18800	1.60E-06	4.36E-05	2.64E-05	CX3CR1/CXCL6/AZGP1/PTPRC/TYROBP/HLA-DRA	6
BP	GO:0002381	immunoglobulin production involved in immunoglobulin-mediated immune response	5/52	73/18800	1.73E-06	4.65E-05	2.82E-05	HLA-DMB/PTPRC/HLA-DMA/HLA-DQB1/HLA-DRA	5
BP	GO:0071222	cellular response to lipopolysaccharide	7/52	217/18800	2.13E-06	5.62E-05	3.41E-05	CX3CR1/LTF/CXCL6/CCL5/HCK/CXCL9/CD14	7
BP	GO:0002705	positive regulation of leukocyte mediated immunity	6/52	138/18800	2.16E-06	5.62E-05	3.41E-05	ITGB2/AZGP1/PTPRC/TYROBP/C3/HLA-DRA	6
BP	GO:0050870	positive regulation of T cell activation	7/52	223/18800	2.56E-06	6.54E-05	3.96E-05	HLA-DMB/PTPRC/HLA-DMA/CCL5/HLA-DQB1/VCAM1/HLA-DRA	7
BP	GO:0032103	positive regulation of response to external stimulus	9/52	442/18800	3.04E-06	7.55E-05	4.58E-05	CX3CR1/APOH/HRG/CCL5/HCK/RAC2/TYROBP/C3/S100A8	9
BP	GO:0071219	cellular response to molecule of bacterial origin	7/52	229/18800	3.05E-06	7.55E-05	4.58E-05	CX3CR1/LTF/CXCL6/CCL5/HCK/CXCL9/CD14	7
BP	GO:0050670	regulation of lymphocyte proliferation	7/52	230/18800	3.14E-06	7.66E-05	4.64E-05	HLA-DMB/ARG2/PTPRC/CCL5/RAC2/TYROBP/VCAM1	7
BP	GO:0051235	maintenance of location	8/52	331/18800	3.25E-06	7.74E-05	4.70E-05	TMSB10/ALB/PTPRC/C3/TMSB15A/CXCL9/ANGPTL3/S100A8	8
BP	GO:0045785	positive regulation of cell adhesion	9/52	446/18800	3.27E-06	7.74E-05	4.70E-05	HRG/HLA-DMB/ITGB2/PTPRC/HLA-DMA/CCL5/HLA-DQB1/VCAM1/HLA-DRA	9
BP	GO:0032944	regulation of mononuclear cell proliferation	7/52	233/18800	3.42E-06	7.98E-05	4.84E-05	HLA-DMB/ARG2/PTPRC/CCL5/RAC2/TYROBP/VCAM1	7
BP	GO:0022407	regulation of cell-cell adhesion	9/52	456/18800	3.92E-06	9.01E-05	5.46E-05	HLA-DMB/ITGB2/ARG2/PTPRC/HLA-DMA/CCL5/HLA-DQB1/VCAM1/HLA-DRA	9
BP	GO:0045069	regulation of viral genome replication	5/52	87/18800	4.14E-06	9.26E-05	5.61E-05	LTF/ISG20/IFITM1/CCL5/ISG15	5
BP	GO:0050829	defense response to Gram-negative bacterium	5/52	87/18800	4.14E-06	9.26E-05	5.61E-05	LTF/CXCL6/LYZ/DEFB1/IGHM	5
BP	GO:0002831	regulation of response to biotic stimulus	8/52	351/18800	5.01E-06	0.000110613	6.71E-05	HRG/LTF/CXCL6/ARG2/CCL5/HCK/TYROBP/ISG15	8
BP	GO:0048525	negative regulation of viral process	5/52	91/18800	5.16E-06	0.000112439	6.82E-05	LTF/ISG20/IFITM1/CCL5/ISG15	5
BP	GO:0002275	myeloid cell activation involved in immune response	5/52	93/18800	5.75E-06	0.000123466	7.49E-05	CX3CR1/FCER1G/ITGB2/RAC2/TYROBP	5
BP	GO:0070663	regulation of leukocyte proliferation	7/52	254/18800	6.03E-06	0.000127747	7.75E-05	HLA-DMB/ARG2/PTPRC/CCL5/RAC2/TYROBP/VCAM1	7
BP	GO:0002764	immune response-regulating signaling pathway	9/52	482/18800	6.14E-06	0.000128357	7.78E-05	LTF/FCER1G/CTSS/PTPRC/HCK/TYROBP/HLA-DQB1/CD14/IGHM	9
BP	GO:0071216	cellular response to biotic stimulus	7/52	256/18800	6.34E-06	0.00013103	7.95E-05	CX3CR1/LTF/CXCL6/CCL5/HCK/CXCL9/CD14	7
BP	GO:0042129	regulation of T cell proliferation	6/52	174/18800	8.25E-06	0.000168199	0.000101989	HLA-DMB/ARG2/PTPRC/CCL5/RAC2/VCAM1	6
BP	GO:0001774	microglial cell activation	4/52	47/18800	8.50E-06	0.000171161	0.000103785	CX3CR1/ITGB2/PTPRC/TYROBP	4
BP	GO:0051702	biological process involved in interaction with symbiont	5/52	101/18800	8.62E-06	0.000171355	0.000103902	CX3CR1/HRG/LTF/CXCL6/CCL5	5
BP	GO:0002269	leukocyte activation involved in inflammatory response	4/52	50/18800	1.09E-05	0.000214292	0.000129937	CX3CR1/ITGB2/PTPRC/TYROBP	4
BP	GO:0002544	chronic inflammatory response	3/52	17/18800	1.32E-05	0.000256315	0.000155418	CCL5/VCAM1/S100A8	3
BP	GO:0050832	defense response to fungus	4/52	53/18800	1.38E-05	0.000264359	0.000160296	CX3CR1/HRG/LTF/S100A8	4
BP	GO:0061900	glial cell activation	4/52	54/18800	1.49E-05	0.000281574	0.000170735	CX3CR1/ITGB2/PTPRC/TYROBP	4
BP	GO:0046651	lymphocyte proliferation	7/52	296/18800	1.63E-05	0.000305261	0.000185097	HLA-DMB/ARG2/PTPRC/CCL5/RAC2/TYROBP/VCAM1	7
BP	GO:0032943	mononuclear cell proliferation	7/52	300/18800	1.78E-05	0.000329017	0.000199502	HLA-DMB/ARG2/PTPRC/CCL5/RAC2/TYROBP/VCAM1	7
BP	GO:0002283	neutrophil activation involved in immune response	3/52	19/18800	1.87E-05	0.000339296	0.000205735	FCER1G/ITGB2/TYROBP	3
BP	GO:0002888	positive regulation of myeloid leukocyte mediated immunity	3/52	19/18800	1.87E-05	0.000339296	0.000205735	ITGB2/TYROBP/C3	3
BP	GO:0001912	positive regulation of leukocyte mediated cytotoxicity	4/52	58/18800	1.98E-05	0.000353862	0.000214567	AZGP1/PTPRC/TYROBP/HLA-DRA	4
BP	GO:0042098	T cell proliferation	6/52	204/18800	2.04E-05	0.000358075	0.000217121	HLA-DMB/ARG2/PTPRC/CCL5/RAC2/VCAM1	6
BP	GO:0052548	regulation of endopeptidase activity	8/52	426/18800	2.04E-05	0.000358075	0.000217121	PSMB8/HRG/LTF/TNFSF10/C3/KNG1/SERPINA3/S100A8	8
BP	GO:0032102	negative regulation of response to external stimulus	8/52	429/18800	2.15E-05	0.000372499	0.000225868	APOH/HRG/LTF/ARG2/PTPRC/HCK/ISG15/KNG1	8
BP	GO:0031663	lipopolysaccharide-mediated signaling pathway	4/52	62/18800	2.58E-05	0.000441851	0.00026792	LTF/CCL5/HCK/CD14	4
BP	GO:0009620	response to fungus	4/52	64/18800	2.92E-05	0.000495936	0.000300715	CX3CR1/HRG/LTF/S100A8	4
BP	GO:0035584	calcium-mediated signaling using intracellular calcium source	3/52	22/18800	2.96E-05	0.000496991	0.000301354	PTPRC/VCAM1/DEFB1	3
BP	GO:0051651	maintenance of location in cell	6/52	219/18800	3.04E-05	0.000504478	0.000305894	TMSB10/ALB/PTPRC/TMSB15A/CXCL9/S100A8	6
BP	GO:0031343	positive regulation of cell killing	4/52	65/18800	3.11E-05	0.000511235	0.000309991	AZGP1/PTPRC/TYROBP/HLA-DRA	4
BP	GO:0070661	leukocyte proliferation	7/52	330/18800	3.27E-05	0.000532392	0.00032282	HLA-DMB/ARG2/PTPRC/CCL5/RAC2/TYROBP/VCAM1	7
BP	GO:0052547	regulation of peptidase activity	8/52	456/18800	3.32E-05	0.000535467	0.000324684	PSMB8/HRG/LTF/TNFSF10/C3/KNG1/SERPINA3/S100A8	8
BP	GO:0019079	viral genome replication	5/52	134/18800	3.39E-05	0.000540764	0.000327896	LTF/ISG20/IFITM1/CCL5/ISG15	5
BP	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	3/52	24/18800	3.88E-05	0.000612368	0.000371314	TYROBP/CXCL9/GDF15	3
BP	GO:1903900	regulation of viral life cycle	5/52	139/18800	4.04E-05	0.000631995	0.000383215	LTF/ISG20/IFITM1/CCL5/ISG15	5
BP	GO:0150076	neuroinflammatory response	4/52	73/18800	4.92E-05	0.000761928	0.000462001	CX3CR1/ITGB2/PTPRC/TYROBP	4
BP	GO:0001895	retina homeostasis	4/52	80/18800	7.05E-05	0.001081062	0.00065551	LTF/ALB/AZGP1/LYZ	4
BP	GO:0050792	regulation of viral process	5/52	159/18800	7.66E-05	0.001136091	0.000688877	LTF/ISG20/IFITM1/CCL5/ISG15	5
BP	GO:0001916	positive regulation of T cell mediated cytotoxicity	3/52	30/18800	7.69E-05	0.001136091	0.000688877	AZGP1/PTPRC/HLA-DRA	3
BP	GO:0038094	Fc-gamma receptor signaling pathway	3/52	30/18800	7.69E-05	0.001136091	0.000688877	FCER1G/PTPRC/HCK	3
BP	GO:0060142	regulation of syncytium formation by plasma membrane fusion	3/52	30/18800	7.69E-05	0.001136091	0.000688877	TYROBP/CXCL9/GDF15	3
BP	GO:0002253	activation of immune response	7/52	386/18800	8.79E-05	0.001287781	0.000780856	FCER1G/PTPRC/HCK/TYROBP/C3/HLA-DQB1/IGHM	7
BP	GO:0002431	Fc receptor mediated stimulatory signaling pathway	3/52	33/18800	0.000102695	0.001490464	0.000903754	FCER1G/PTPRC/HCK	3
BP	GO:0070098	chemokine-mediated signaling pathway	4/52	89/18800	0.000106799	0.001536187	0.000931479	CX3CR1/CXCL6/CCL5/CXCL9	4
BP	GO:0044403	biological process involved in symbiotic interaction	6/52	286/18800	0.000133051	0.001896861	0.001150176	CX3CR1/HRG/LTF/CXCL6/IFITM1/CCL5	6
BP	GO:0045730	respiratory burst	3/52	37/18800	0.000145113	0.002050672	0.00124344	CYBB/HCK/RAC2	3
BP	GO:1990868	response to chemokine	4/52	97/18800	0.000149105	0.002070762	0.001255622	CX3CR1/CXCL6/CCL5/CXCL9	4
BP	GO:1990869	cellular response to chemokine	4/52	97/18800	0.000149105	0.002070762	0.001255622	CX3CR1/CXCL6/CCL5/CXCL9	4
BP	GO:0002683	negative regulation of immune system process	7/52	425/18800	0.000159687	0.002198767	0.001333239	CX3CR1/LTF/ARG2/PTPRC/HCK/TYROBP/ISG15	7
BP	GO:0050764	regulation of phagocytosis	4/52	99/18800	0.000161337	0.002202657	0.001335598	FCER1G/PTPRC/HCK/C3	4
BP	GO:0002819	regulation of adaptive immune response	5/52	188/18800	0.000168344	0.002279007	0.001381893	AZGP1/CD48/PTPRC/C3/HLA-DRA	5
BP	GO:0002429	immune response-activating cell surface receptor signaling pathway	6/52	300/18800	0.000172528	0.00229705	0.001392834	FCER1G/PTPRC/HCK/TYROBP/HLA-DQB1/IGHM	6
BP	GO:0002757	immune response-activating signal transduction	6/52	300/18800	0.000172528	0.00229705	0.001392834	FCER1G/PTPRC/HCK/TYROBP/HLA-DQB1/IGHM	6
BP	GO:0001914	regulation of T cell mediated cytotoxicity	3/52	40/18800	0.000183442	0.002422341	0.001468805	AZGP1/PTPRC/HLA-DRA	3
BP	GO:0032760	positive regulation of tumor necrosis factor production	4/52	103/18800	0.000187953	0.002441878	0.001480651	CYBB/PTPRC/TYROBP/CD14	4
BP	GO:0042102	positive regulation of T cell proliferation	4/52	103/18800	0.000187953	0.002441878	0.001480651	HLA-DMB/PTPRC/CCL5/VCAM1	4
BP	GO:0046425	regulation of receptor signaling pathway via JAK-STAT	4/52	105/18800	0.000202387	0.002608365	0.001581602	IL10RA/PTPRC/CCL5/EGF	4
BP	GO:0042116	macrophage activation	4/52	106/18800	0.000209896	0.002683671	0.001627264	CX3CR1/ITGB2/PTPRC/TYROBP	4
BP	GO:1901214	regulation of neuron death	6/52	313/18800	0.000216999	0.002717518	0.001647788	CX3CR1/NR4A2/ITGB2/CCL5/TYROBP/FOS	6
BP	GO:0007229	integrin-mediated signaling pathway	4/52	107/18800	0.000217604	0.002717518	0.001647788	ITGB2/HCK/ISG15/ANGPTL3	4
BP	GO:1903557	positive regulation of tumor necrosis factor superfamily cytokine production	4/52	107/18800	0.000217604	0.002717518	0.001647788	CYBB/PTPRC/TYROBP/CD14	4
BP	GO:0042554	superoxide anion generation	3/52	43/18800	0.000227799	0.002822956	0.001711721	CYBB/ITGB2/TYROBP	3
BP	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	4/52	110/18800	0.000241952	0.002975452	0.001804188	AZGP1/PTPRC/C3/HLA-DRA	4
BP	GO:0002526	acute inflammatory response	4/52	113/18800	0.000268202	0.003273284	0.001984781	C3/VCAM1/SERPINA3/S100A8	4
BP	GO:0002768	immune response-regulating cell surface receptor signaling pathway	6/52	328/18800	0.000279076	0.003380384	0.002049722	FCER1G/PTPRC/HCK/TYROBP/HLA-DQB1/IGHM	6
BP	GO:0002821	positive regulation of adaptive immune response	4/52	115/18800	0.000286801	0.003448038	0.002090744	AZGP1/PTPRC/C3/HLA-DRA	4
BP	GO:1904892	regulation of receptor signaling pathway via STAT	4/52	116/18800	0.00029644	0.003537523	0.002145004	IL10RA/PTPRC/CCL5/EGF	4
BP	GO:0002708	positive regulation of lymphocyte mediated immunity	4/52	117/18800	0.00030631	0.003628422	0.002200121	AZGP1/PTPRC/C3/HLA-DRA	4
BP	GO:0001819	positive regulation of cytokine production	7/52	475/18800	0.000314729	0.003690882	0.002237994	FCER1G/CYBB/PTPRC/TYROBP/C3/ISG15/CD14	7
BP	GO:0030195	negative regulation of blood coagulation	3/52	48/18800	0.000316165	0.003690882	0.002237994	APOH/HRG/KNG1	3
BP	GO:0045471	response to ethanol	4/52	119/18800	0.000326753	0.003786736	0.002296116	CYBB/VCAM1/CD14/S100A8	4
BP	GO:0009991	response to extracellular stimulus	7/52	479/18800	0.000331079	0.003786736	0.002296116	NR4A2/ALB/CYBB/PTPRC/VCAM1/FOS/GDF15	7
BP	GO:0051918	negative regulation of fibrinolysis	2/52	10/18800	0.000332913	0.003786736	0.002296116	APOH/HRG	2
BP	GO:0002377	immunoglobulin production	5/52	218/18800	0.000334067	0.003786736	0.002296116	HLA-DMB/PTPRC/HLA-DMA/HLA-DQB1/HLA-DRA	5
BP	GO:1900047	negative regulation of hemostasis	3/52	49/18800	0.000336129	0.003786736	0.002296116	APOH/HRG/KNG1	3
BP	GO:0001913	T cell mediated cytotoxicity	3/52	50/18800	0.000356887	0.003992678	0.002420991	AZGP1/PTPRC/HLA-DRA	3
BP	GO:0045765	regulation of angiogenesis	6/52	345/18800	0.000365498	0.00406081	0.002462303	CX3CR1/APOH/HRG/CYBB/C3/ANGPTL3	6
BP	GO:0043277	apoptotic cell clearance	3/52	51/18800	0.000378455	0.004175962	0.002532126	RAC2/TYROBP/C3	3
BP	GO:0010038	response to metal ion	6/52	351/18800	0.000400562	0.004276768	0.002593251	CYBB/SDC1/VCAM1/FOS/CD14/S100A8	6
BP	GO:1901342	regulation of vasculature development	6/52	351/18800	0.000400562	0.004276768	0.002593251	CX3CR1/APOH/HRG/CYBB/C3/ANGPTL3	6
BP	GO:0038093	Fc receptor signaling pathway	3/52	52/18800	0.000400844	0.004276768	0.002593251	FCER1G/PTPRC/HCK	3
BP	GO:0050819	negative regulation of coagulation	3/52	52/18800	0.000400844	0.004276768	0.002593251	APOH/HRG/KNG1	3
BP	GO:0042989	sequestering of actin monomers	2/52	11/18800	0.000406173	0.004276768	0.002593251	TMSB10/TMSB15A	2
BP	GO:0098883	synapse pruning	2/52	11/18800	0.000406173	0.004276768	0.002593251	CX3CR1/C3	2
BP	GO:2001204	regulation of osteoclast development	2/52	11/18800	0.000406173	0.004276768	0.002593251	LTF/TYROBP	2
BP	GO:0070997	neuron death	6/52	353/18800	0.000412818	0.004318505	0.002618558	CX3CR1/NR4A2/ITGB2/CCL5/TYROBP/FOS	6
BP	GO:0006911	phagocytosis, engulfment	4/52	128/18800	0.000431013	0.00447975	0.00271633	ITGB2/RAC2/C3/IGHM	4
BP	GO:0072593	reactive oxygen species metabolic process	5/52	231/18800	0.000435528	0.004497665	0.002727193	CYBB/ITGB2/ARG2/RAC2/TYROBP	5
BP	GO:0006968	cellular defense response	3/52	54/18800	0.000448138	0.004598413	0.002788282	CX3CR1/TYROBP/CXCL9	3
BP	GO:0097305	response to alcohol	5/52	235/18800	0.000470989	0.004802301	0.002911912	CYBB/VCAM1/FOS/CD14/S100A8	5
BP	GO:1900272	negative regulation of long-term synaptic potentiation	2/52	12/18800	0.000486545	0.004929714	0.002989169	CX3CR1/TYROBP	2
BP	GO:0043903	regulation of biological process involved in symbiotic interaction	3/52	56/18800	0.000498875	0.004991847	0.003026844	LTF/CXCL6/IFITM1	3
BP	GO:0061756	leukocyte adhesion to vascular endothelial cell	3/52	56/18800	0.000498875	0.004991847	0.003026844	CX3CR1/ITGB2/VCAM1	3
BP	GO:0051346	negative regulation of hydrolase activity	6/52	371/18800	0.000536848	0.005305903	0.003217275	HRG/LTF/C3/KNG1/SERPINA3/ANGPTL3	6
BP	GO:1903706	regulation of hemopoiesis	6/52	371/18800	0.000536848	0.005305903	0.003217275	LTF/PTPRC/TYROBP/ISG15/FOS/HLA-DRA	6
BP	GO:0018108	peptidyl-tyrosine phosphorylation	6/52	373/18800	0.000552247	0.005416442	0.003284301	HRG/ITGB2/PTPRC/CCL5/HCK/EGF	6
BP	GO:0099024	plasma membrane invagination	4/52	137/18800	0.000557116	0.005416442	0.003284301	ITGB2/RAC2/C3/IGHM	4
BP	GO:0031668	cellular response to extracellular stimulus	5/52	245/18800	0.000569174	0.005416442	0.003284301	NR4A2/ALB/PTPRC/VCAM1/FOS	5
BP	GO:0070486	leukocyte aggregation	2/52	13/18800	0.00057399	0.005416442	0.003284301	RAC2/S100A8	2
BP	GO:0018212	peptidyl-tyrosine modification	6/52	376/18800	0.000575988	0.005416442	0.003284301	HRG/ITGB2/PTPRC/CCL5/HCK/EGF	6
BP	GO:0006898	receptor-mediated endocytosis	5/52	246/18800	0.000579778	0.005416442	0.003284301	FCER1G/ITGB2/C3/EGF/CD14	5
BP	GO:0071695	anatomical structure maturation	5/52	246/18800	0.000579778	0.005416442	0.003284301	CX3CR1/NR4A2/LTF/C3/DEFB1	5
BP	GO:0000768	syncytium formation by plasma membrane fusion	3/52	59/18800	0.000581654	0.005416442	0.003284301	TYROBP/CXCL9/GDF15	3
BP	GO:0002711	positive regulation of T cell mediated immunity	3/52	59/18800	0.000581654	0.005416442	0.003284301	AZGP1/PTPRC/HLA-DRA	3
BP	GO:0140253	cell-cell fusion	3/52	59/18800	0.000581654	0.005416442	0.003284301	TYROBP/CXCL9/GDF15	3
BP	GO:0009636	response to toxic substance	5/52	247/18800	0.000590529	0.005467482	0.00331525	ALB/APOM/CCL5/SDC1/FOS	5
BP	GO:0034341	response to interferon-gamma	4/52	140/18800	0.000604424	0.005564153	0.003373867	GBP2/IFITM1/CCL5/HCK	4
BP	GO:0019731	antibacterial humoral response	3/52	60/18800	0.000611076	0.005593431	0.00339162	LTF/DEFB1/IGHM	3
BP	GO:0050671	positive regulation of lymphocyte proliferation	4/52	141/18800	0.000620808	0.005650406	0.003426167	HLA-DMB/PTPRC/CCL5/VCAM1	4
BP	GO:0010951	negative regulation of endopeptidase activity	5/52	251/18800	0.00063504	0.005747469	0.003485021	HRG/LTF/C3/KNG1/SERPINA3	5
BP	GO:0034113	heterotypic cell-cell adhesion	3/52	61/18800	0.000641434	0.005772903	0.003500444	ITGB2/PTPRC/VCAM1	3
BP	GO:0032946	positive regulation of mononuclear cell proliferation	4/52	143/18800	0.000654519	0.005857948	0.003552011	HLA-DMB/PTPRC/CCL5/VCAM1	4
BP	GO:0051917	regulation of fibrinolysis	2/52	14/18800	0.00066847	0.005947007	0.003606013	APOH/HRG	2
BP	GO:0010324	membrane invagination	4/52	144/18800	0.000671853	0.005947007	0.003606013	ITGB2/RAC2/C3/IGHM	4
BP	GO:0006949	syncytium formation	3/52	63/18800	0.000705001	0.006206322	0.003763251	TYROBP/CXCL9/GDF15	3
BP	GO:0009615	response to virus	6/52	392/18800	0.000716366	0.006272099	0.003803135	ISG20/IFITM1/PTPRC/CCL5/ISG15/CXCL9	6
BP	GO:2000377	regulation of reactive oxygen species metabolic process	4/52	147/18800	0.000725807	0.006320408	0.003832428	ITGB2/ARG2/RAC2/TYROBP	4
BP	GO:0045670	regulation of osteoclast differentiation	3/52	64/18800	0.000738235	0.006394069	0.003877092	LTF/TYROBP/FOS	3
BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	5/52	261/18800	0.000757336	0.006524429	0.003956137	HRG/ITGB2/PTPRC/CCL5/EGF	5
BP	GO:0010466	negative regulation of peptidase activity	5/52	262/18800	0.000770469	0.006602263	0.004003333	HRG/LTF/C3/KNG1/SERPINA3	5
BP	GO:0030193	regulation of blood coagulation	3/52	66/18800	0.000807662	0.006884353	0.00417438	APOH/HRG/KNG1	3
BP	GO:0051851	modulation by host of symbiont process	3/52	67/18800	0.000843877	0.007155189	0.004338603	CX3CR1/LTF/CCL5	3
BP	GO:1901741	positive regulation of myoblast fusion	2/52	16/18800	0.000878383	0.007393057	0.004482836	CXCL9/GDF15	2
BP	GO:1900046	regulation of hemostasis	3/52	68/18800	0.000881109	0.007393057	0.004482836	APOH/HRG/KNG1	3
BP	GO:0001894	tissue homeostasis	5/52	272/18800	0.00091137	0.007607342	0.00461277	LTF/ALB/AZGP1/LYZ/SERPINA3	5
BP	GO:1902107	positive regulation of leukocyte differentiation	4/52	157/18800	0.000927843	0.007665412	0.004647981	PTPRC/TYROBP/FOS/HLA-DRA	4
BP	GO:1903708	positive regulation of hemopoiesis	4/52	157/18800	0.000927843	0.007665412	0.004647981	PTPRC/TYROBP/FOS/HLA-DRA	4
BP	GO:0070665	positive regulation of leukocyte proliferation	4/52	158/18800	0.000950012	0.007808514	0.004734752	HLA-DMB/PTPRC/CCL5/VCAM1	4
BP	GO:0050766	positive regulation of phagocytosis	3/52	71/18800	0.000999017	0.008128369	0.004928699	FCER1G/PTPRC/C3	3
BP	GO:0050818	regulation of coagulation	3/52	71/18800	0.000999017	0.008128369	0.004928699	APOH/HRG/KNG1	3
BP	GO:0006801	superoxide metabolic process	3/52	72/18800	0.001040427	0.008422757	0.005107203	CYBB/ITGB2/TYROBP	3
BP	GO:1902105	regulation of leukocyte differentiation	5/52	283/18800	0.001087667	0.008761157	0.005312394	LTF/PTPRC/TYROBP/FOS/HLA-DRA	5
BP	GO:0002281	macrophage activation involved in immune response	2/52	18/18800	0.001115981	0.008900221	0.005396717	CX3CR1/TYROBP	2
BP	GO:0036035	osteoclast development	2/52	18/18800	0.001115981	0.008900221	0.005396717	LTF/TYROBP	2
BP	GO:0042060	wound healing	6/52	429/18800	0.001142603	0.009067654	0.005498241	APOH/HRG/FCER1G/SDC1/KNG1/S100A8	6
BP	GO:0031349	positive regulation of defense response	5/52	289/18800	0.001193902	0.009428312	0.005716929	CCL5/HCK/TYROBP/C3/S100A8	5
BP	GO:0051607	defense response to virus	5/52	290/18800	0.00121233	0.009470586	0.005742562	ISG20/IFITM1/PTPRC/ISG15/CXCL9	5
BP	GO:0043299	leukocyte degranulation	3/52	76/18800	0.001216891	0.009470586	0.005742562	ITGB2/HCK/RAC2	3
BP	GO:0061045	negative regulation of wound healing	3/52	76/18800	0.001216891	0.009470586	0.005742562	APOH/HRG/KNG1	3
BP	GO:0140546	defense response to symbiont	5/52	291/18800	0.001230968	0.009534083	0.005781063	ISG20/IFITM1/PTPRC/ISG15/CXCL9	5
BP	GO:0002483	antigen processing and presentation of endogenous peptide antigen	2/52	19/18800	0.001245067	0.009551443	0.00579159	AZGP1/HLA-DRA	2
BP	GO:0032930	positive regulation of superoxide anion generation	2/52	19/18800	0.001245067	0.009551443	0.00579159	ITGB2/TYROBP	2
BP	GO:0021700	developmental maturation	5/52	296/18800	0.001327366	0.010051393	0.006094739	CX3CR1/NR4A2/LTF/C3/DEFB1	5
BP	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	4/52	173/18800	0.001328955	0.010051393	0.006094739	AZGP1/PTPRC/C3/HLA-DRA	4
BP	GO:0007259	receptor signaling pathway via JAK-STAT	4/52	173/18800	0.001328955	0.010051393	0.006094739	IL10RA/PTPRC/CCL5/EGF	4
BP	GO:0042053	regulation of dopamine metabolic process	2/52	20/18800	0.001380962	0.01019862	0.006184011	NR4A2/ITGB2	2
BP	GO:0042069	regulation of catecholamine metabolic process	2/52	20/18800	0.001380962	0.01019862	0.006184011	NR4A2/ITGB2	2
BP	GO:0051004	regulation of lipoprotein lipase activity	2/52	20/18800	0.001380962	0.01019862	0.006184011	APOH/ANGPTL3	2
BP	GO:0070233	negative regulation of T cell apoptotic process	2/52	20/18800	0.001380962	0.01019862	0.006184011	ARG2/CCL5	2
BP	GO:0090026	positive regulation of monocyte chemotaxis	2/52	20/18800	0.001380962	0.01019862	0.006184011	CX3CR1/CCL5	2
BP	GO:0002706	regulation of lymphocyte mediated immunity	4/52	175/18800	0.001386405	0.01019862	0.006184011	AZGP1/PTPRC/C3/HLA-DRA	4
BP	GO:0050777	negative regulation of immune response	4/52	179/18800	0.001506477	0.011007026	0.006674194	ARG2/PTPRC/HCK/ISG15	4
BP	GO:0071404	cellular response to low-density lipoprotein particle stimulus	2/52	21/18800	0.001523629	0.011007026	0.006674194	FCER1G/ITGB2	2
BP	GO:0150146	cell junction disassembly	2/52	21/18800	0.001523629	0.011007026	0.006674194	CX3CR1/C3	2
BP	GO:1901739	regulation of myoblast fusion	2/52	21/18800	0.001523629	0.011007026	0.006674194	CXCL9/GDF15	2
BP	GO:0002833	positive regulation of response to biotic stimulus	4/52	180/18800	0.001537592	0.01105831	0.00670529	HRG/CCL5/HCK/TYROBP	4
BP	GO:0071496	cellular response to external stimulus	5/52	309/18800	0.001604127	0.011485552	0.006964352	NR4A2/ALB/PTPRC/VCAM1/FOS	5
BP	GO:0045766	positive regulation of angiogenesis	4/52	183/18800	0.001633628	0.011593719	0.00702994	CX3CR1/CYBB/C3/ANGPTL3	4
BP	GO:1904018	positive regulation of vasculature development	4/52	183/18800	0.001633628	0.011593719	0.00702994	CX3CR1/CYBB/C3/ANGPTL3	4
BP	GO:0097696	receptor signaling pathway via STAT	4/52	184/18800	0.001666547	0.011722549	0.007108057	IL10RA/PTPRC/CCL5/EGF	4
BP	GO:0032928	regulation of superoxide anion generation	2/52	22/18800	0.001673031	0.011722549	0.007108057	ITGB2/TYROBP	2
BP	GO:0002440	production of molecular mediator of immune response	5/52	312/18800	0.00167361	0.011722549	0.007108057	HLA-DMB/PTPRC/HLA-DMA/HLA-DQB1/HLA-DRA	5
BP	GO:0033627	cell adhesion mediated by integrin	3/52	86/18800	0.001737411	0.012116752	0.007347085	HRG/ITGB2/CCL5	3
BP	GO:0019058	viral life cycle	5/52	317/18800	0.001794309	0.012364565	0.007497348	LTF/ISG20/IFITM1/CCL5/ISG15	5
BP	GO:0001960	negative regulation of cytokine-mediated signaling pathway	3/52	87/18800	0.00179597	0.012364565	0.007497348	PTPRC/CCL5/ISG15	3
BP	GO:1901216	positive regulation of neuron death	3/52	87/18800	0.00179597	0.012364565	0.007497348	ITGB2/TYROBP/FOS	3
BP	GO:0030194	positive regulation of blood coagulation	2/52	23/18800	0.00182913	0.012486134	0.007571063	APOH/HRG	2
BP	GO:1900048	positive regulation of hemostasis	2/52	23/18800	0.00182913	0.012486134	0.007571063	APOH/HRG	2
BP	GO:0060249	anatomical structure homeostasis	5/52	319/18800	0.001844338	0.012536828	0.007601801	LTF/ALB/AZGP1/LYZ/SERPINA3	5
BP	GO:0002709	regulation of T cell mediated immunity	3/52	88/18800	0.00185575	0.012561401	0.007616701	AZGP1/PTPRC/HLA-DRA	3
BP	GO:0060191	regulation of lipase activity	3/52	90/18800	0.001979009	0.013151368	0.007974432	APOH/CCL5/ANGPTL3	3
BP	GO:0061097	regulation of protein tyrosine kinase activity	3/52	90/18800	0.001979009	0.013151368	0.007974432	PTPRC/CCL5/EGF	3
BP	GO:0002922	positive regulation of humoral immune response	2/52	24/18800	0.001991889	0.013151368	0.007974432	PTPRC/C3	2
BP	GO:0042730	fibrinolysis	2/52	24/18800	0.001991889	0.013151368	0.007974432	APOH/HRG	2
BP	GO:0045672	positive regulation of osteoclast differentiation	2/52	24/18800	0.001991889	0.013151368	0.007974432	TYROBP/FOS	2
BP	GO:0050820	positive regulation of coagulation	2/52	24/18800	0.001991889	0.013151368	0.007974432	APOH/HRG	2
BP	GO:0060761	negative regulation of response to cytokine stimulus	3/52	92/18800	0.00210726	0.013799983	0.008367725	PTPRC/CCL5/ISG15	3
BP	GO:1903035	negative regulation of response to wounding	3/52	92/18800	0.00210726	0.013799983	0.008367725	APOH/HRG/KNG1	3
BP	GO:0001911	negative regulation of leukocyte mediated cytotoxicity	2/52	25/18800	0.002161273	0.013983178	0.008478806	CX3CR1/PTPRC	2
BP	GO:0035821	modulation of process of another organism	2/52	25/18800	0.002161273	0.013983178	0.008478806	LTF/REG1A	2
BP	GO:1905523	positive regulation of macrophage migration	2/52	25/18800	0.002161273	0.013983178	0.008478806	CX3CR1/CCL5	2
BP	GO:0002690	positive regulation of leukocyte chemotaxis	3/52	94/18800	0.002240573	0.014438254	0.008754745	CX3CR1/CCL5/RAC2	3
BP	GO:0002285	lymphocyte activation involved in immune response	4/52	201/18800	0.002299191	0.014731156	0.008932349	HLA-DMB/FCER1G/PTPRC/HLA-DRA	4
BP	GO:0072503	cellular divalent inorganic cation homeostasis	6/52	494/18800	0.002335224	0.014731156	0.008932349	CX3CR1/PTPRC/CCL5/CXCL9/KNG1/S100A8	6
BP	GO:0002433	immune response-regulating cell surface receptor signaling pathway involved in phagocytosis	2/52	26/18800	0.002337245	0.014731156	0.008932349	PTPRC/HCK	2
BP	GO:0019883	antigen processing and presentation of endogenous antigen	2/52	26/18800	0.002337245	0.014731156	0.008932349	AZGP1/HLA-DRA	2
BP	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	2/52	26/18800	0.002337245	0.014731156	0.008932349	PTPRC/HCK	2
BP	GO:0019722	calcium-mediated signaling	4/52	202/18800	0.002340891	0.014731156	0.008932349	CX3CR1/PTPRC/VCAM1/DEFB1	4
BP	GO:0030316	osteoclast differentiation	3/52	96/18800	0.002379018	0.01491283	0.009042508	LTF/TYROBP/FOS	3
BP	GO:0045807	positive regulation of endocytosis	3/52	97/18800	0.002450185	0.015299411	0.009276914	C3/EGF/CD14	3
BP	GO:0002227	innate immune response in mucosa	2/52	27/18800	0.002519768	0.015673154	0.009503536	LTF/DEFB1	2
BP	GO:0045639	positive regulation of myeloid cell differentiation	3/52	99/18800	0.002596452	0.01606132	0.009738904	TYROBP/ISG15/FOS	3
BP	GO:0045637	regulation of myeloid cell differentiation	4/52	208/18800	0.002602113	0.01606132	0.009738904	LTF/TYROBP/ISG15/FOS	4
BP	GO:0002758	innate immune response-activating signal transduction	2/52	28/18800	0.002708807	0.016529879	0.010023018	HCK/TYROBP	2
BP	GO:0031342	negative regulation of cell killing	2/52	28/18800	0.002708807	0.016529879	0.010023018	CX3CR1/PTPRC	2
BP	GO:0090025	regulation of monocyte chemotaxis	2/52	28/18800	0.002708807	0.016529879	0.010023018	CX3CR1/CCL5	2
BP	GO:0045861	negative regulation of proteolysis	5/52	350/18800	0.002757695	0.016764701	0.010165404	HRG/LTF/C3/KNG1/SERPINA3	5
BP	GO:0032956	regulation of actin cytoskeleton organization	5/52	352/18800	0.002826125	0.017116115	0.010378487	TMSB10/HRG/HCK/RAC2/TMSB15A	5
BP	GO:0002474	antigen processing and presentation of peptide antigen via MHC class I	2/52	29/18800	0.002904325	0.017523848	0.010625718	FCER1G/AZGP1	2
BP	GO:0043491	protein kinase B signaling	4/52	216/18800	0.002980716	0.017879279	0.010841237	CX3CR1/CCL5/EGF/GDF15	4
BP	GO:0050830	defense response to Gram-positive bacterium	3/52	104/18800	0.002985429	0.017879279	0.010841237	GBP2/LYZ/DEFB1	3
BP	GO:0006887	exocytosis	5/52	357/18800	0.003002591	0.017915458	0.010863174	ITGB2/CCL5/HCK/SDC1/RAC2	5
BP	GO:0046634	regulation of alpha-beta T cell activation	3/52	105/18800	0.003067283	0.018233923	0.011056278	ARG2/PTPRC/HLA-DRA	3
BP	GO:0051873	killing by host of symbiont cells	2/52	30/18800	0.003106286	0.018397893	0.011155702	HRG/CXCL6	2
BP	GO:0001818	negative regulation of cytokine production	5/52	363/18800	0.003224743	0.019023884	0.011535277	CX3CR1/LTF/ARG2/PTPRC/TYROBP	5
BP	GO:0007596	blood coagulation	4/52	221/18800	0.003235595	0.019023884	0.011535277	APOH/HRG/FCER1G/KNG1	4
BP	GO:0031589	cell-substrate adhesion	5/52	364/18800	0.003262893	0.019114622	0.011590296	HRG/ITGB2/RAC2/VCAM1/ANGPTL3	5
BP	GO:0050920	regulation of chemotaxis	4/52	225/18800	0.003449934	0.020137117	0.012210294	CX3CR1/HRG/CCL5/RAC2	4
BP	GO:0032611	interleukin-1 beta production	3/52	110/18800	0.003497262	0.020166238	0.012227952	CX3CR1/ARG2/TYROBP	3
BP	GO:0032651	regulation of interleukin-1 beta production	3/52	110/18800	0.003497262	0.020166238	0.012227952	CX3CR1/ARG2/TYROBP	3
BP	GO:2001233	regulation of apoptotic signaling pathway	5/52	370/18800	0.003498685	0.020166238	0.012227952	CX3CR1/NR4A2/PTPRC/TNFSF10/S100A8	5
BP	GO:0050817	coagulation	4/52	226/18800	0.003504995	0.020166238	0.012227952	APOH/HRG/FCER1G/KNG1	4
BP	GO:0051385	response to mineralocorticoid	2/52	32/18800	0.003529396	0.020234366	0.012269261	CYBB/FOS	2
BP	GO:0007599	hemostasis	4/52	227/18800	0.003560652	0.02034117	0.012334023	APOH/HRG/FCER1G/KNG1	4
BP	GO:0002456	T cell mediated immunity	3/52	112/18800	0.003679052	0.020943298	0.012699128	AZGP1/PTPRC/HLA-DRA	3
BP	GO:0050901	leukocyte tethering or rolling	2/52	33/18800	0.003750473	0.021100048	0.012794175	CX3CR1/VCAM1	2
BP	GO:0055094	response to lipoprotein particle	2/52	33/18800	0.003750473	0.021100048	0.012794175	FCER1G/ITGB2	2
BP	GO:0070229	negative regulation of lymphocyte apoptotic process	2/52	33/18800	0.003750473	0.021100048	0.012794175	ARG2/CCL5	2
BP	GO:0002832	negative regulation of response to biotic stimulus	3/52	113/18800	0.003772076	0.021100048	0.012794175	LTF/ARG2/ISG15	3
BP	GO:0031623	receptor internalization	3/52	113/18800	0.003772076	0.021100048	0.012794175	FCER1G/ITGB2/EGF	3
BP	GO:0045088	regulation of innate immune response	4/52	231/18800	0.003789307	0.021123091	0.012808147	CCL5/HCK/TYROBP/ISG15	4
BP	GO:0033238	regulation of cellular amine metabolic process	2/52	34/18800	0.003977852	0.0219463	0.013307306	NR4A2/ITGB2	2
BP	GO:0070232	regulation of T cell apoptotic process	2/52	34/18800	0.003977852	0.0219463	0.013307306	ARG2/CCL5	2
BP	GO:0090322	regulation of superoxide metabolic process	2/52	34/18800	0.003977852	0.0219463	0.013307306	ITGB2/TYROBP	2
BP	GO:0007160	cell-matrix adhesion	4/52	235/18800	0.004027754	0.022145775	0.013428259	HRG/ITGB2/VCAM1/ANGPTL3	4
BP	GO:0002286	T cell activation involved in immune response	3/52	116/18800	0.004059739	0.022245711	0.013488856	HLA-DMB/FCER1G/HLA-DRA	3
BP	GO:0002761	regulation of myeloid leukocyte differentiation	3/52	117/18800	0.004158513	0.022709711	0.013770206	LTF/TYROBP/FOS	3
BP	GO:0002446	neutrophil mediated immunity	2/52	35/18800	0.004211497	0.02284418	0.013851742	CXCL6/ITGB2	2
BP	GO:0098751	bone cell development	2/52	35/18800	0.004211497	0.02284418	0.013851742	LTF/TYROBP	2
BP	GO:0071346	cellular response to interferon-gamma	3/52	118/18800	0.004258742	0.02302293	0.013960129	GBP2/CCL5/HCK	3
BP	GO:0051897	positive regulation of protein kinase B signaling	3/52	119/18800	0.004360431	0.023493829	0.014245662	CX3CR1/EGF/GDF15	3
BP	GO:0071402	cellular response to lipoprotein particle stimulus	2/52	36/18800	0.004451373	0.023903872	0.014494294	FCER1G/ITGB2	2
BP	GO:0032970	regulation of actin filament-based process	5/52	393/18800	0.004517313	0.024177381	0.014660139	TMSB10/HRG/HCK/RAC2/TMSB15A	5
BP	GO:0050727	regulation of inflammatory response	5/52	394/18800	0.004565921	0.024208546	0.014679036	PTPRC/CCL5/HCK/C3/S100A8	5
BP	GO:0002455	humoral immune response mediated by circulating immunoglobulin	3/52	121/18800	0.004568217	0.024208546	0.014679036	PTPRC/C3/IGHM	3
BP	GO:0009308	amine metabolic process	3/52	121/18800	0.004568217	0.024208546	0.014679036	NR4A2/ITGB2/VCAM1	3
BP	GO:0046640	regulation of alpha-beta T cell proliferation	2/52	37/18800	0.004697445	0.024730665	0.014995627	ARG2/PTPRC	2
BP	GO:0071276	cellular response to cadmium ion	2/52	37/18800	0.004697445	0.024730665	0.014995627	CYBB/FOS	2
BP	GO:0002224	toll-like receptor signaling pathway	3/52	123/18800	0.004781921	0.025093401	0.015215575	LTF/CTSS/CD14	3
BP	GO:0002688	regulation of leukocyte chemotaxis	3/52	124/18800	0.004891007	0.025582505	0.015512147	CX3CR1/CCL5/RAC2	3
BP	GO:0043254	regulation of protein-containing complex assembly	5/52	401/18800	0.004916712	0.02563373	0.015543207	TMSB10/HRG/HCK/TMSB15A/ISG15	5
BP	GO:0034612	response to tumor necrosis factor	4/52	249/18800	0.004942248	0.025639651	0.015546797	GBP2/CCL5/VCAM1/CD14	4
BP	GO:0002385	mucosal immune response	2/52	38/18800	0.004949678	0.025639651	0.015546797	LTF/DEFB1	2
BP	GO:0097242	amyloid-beta clearance	2/52	39/18800	0.005208038	0.026891505	0.016305869	ITGB2/C3	2
BP	GO:0032612	interleukin-1 production	3/52	129/18800	0.005459013	0.027987881	0.016970665	CX3CR1/ARG2/TYROBP	3
BP	GO:0032652	regulation of interleukin-1 production	3/52	129/18800	0.005459013	0.027987881	0.016970665	CX3CR1/ARG2/TYROBP	3
BP	GO:0046633	alpha-beta T cell proliferation	2/52	40/18800	0.005472491	0.027987881	0.016970665	ARG2/PTPRC	2
BP	GO:0002251	organ or tissue specific immune response	2/52	41/18800	0.005743001	0.028822351	0.017476652	LTF/DEFB1	2
BP	GO:0002714	positive regulation of B cell mediated immunity	2/52	41/18800	0.005743001	0.028822351	0.017476652	PTPRC/C3	2
BP	GO:0002891	positive regulation of immunoglobulin mediated immune response	2/52	41/18800	0.005743001	0.028822351	0.017476652	PTPRC/C3	2
BP	GO:0010591	regulation of lamellipodium assembly	2/52	41/18800	0.005743001	0.028822351	0.017476652	HRG/RAC2	2
BP	GO:1905521	regulation of macrophage migration	2/52	41/18800	0.005743001	0.028822351	0.017476652	CX3CR1/CCL5	2
BP	GO:2000008	regulation of protein localization to cell surface	2/52	41/18800	0.005743001	0.028822351	0.017476652	TYROBP/EGF	2
BP	GO:0016032	viral process	5/52	418/18800	0.005848062	0.029258472	0.017741097	LTF/ISG20/IFITM1/CCL5/ISG15	5
BP	GO:0061041	regulation of wound healing	3/52	133/18800	0.005940847	0.029630663	0.017966778	APOH/HRG/KNG1	3
BP	GO:0030501	positive regulation of bone mineralization	2/52	42/18800	0.006019535	0.029746844	0.018037225	LTF/ISG15	2
BP	GO:0034142	toll-like receptor 4 signaling pathway	2/52	42/18800	0.006019535	0.029746844	0.018037225	LTF/CD14	2
BP	GO:0042417	dopamine metabolic process	2/52	42/18800	0.006019535	0.029746844	0.018037225	NR4A2/ITGB2	2
BP	GO:2001235	positive regulation of apoptotic signaling pathway	3/52	134/18800	0.00606516	0.02988065	0.01811836	PTPRC/TNFSF10/S100A8	3
BP	GO:0031348	negative regulation of defense response	4/52	268/18800	0.006393603	0.031402725	0.019041281	ARG2/PTPRC/HCK/ISG15	4
BP	GO:0030833	regulation of actin filament polymerization	3/52	139/18800	0.00671011	0.032857103	0.019923154	TMSB10/HCK/TMSB15A	3
BP	GO:0045089	positive regulation of innate immune response	3/52	140/18800	0.006843811	0.032912871	0.01995697	CCL5/HCK/TYROBP	3
BP	GO:0050921	positive regulation of chemotaxis	3/52	140/18800	0.006843811	0.032912871	0.01995697	CX3CR1/CCL5/RAC2	3
BP	GO:0002861	regulation of inflammatory response to antigenic stimulus	2/52	45/18800	0.00688494	0.032912871	0.01995697	HCK/C3	2
BP	GO:0002920	regulation of humoral immune response	2/52	45/18800	0.00688494	0.032912871	0.01995697	PTPRC/C3	2
BP	GO:0007520	myoblast fusion	2/52	45/18800	0.00688494	0.032912871	0.01995697	CXCL9/GDF15	2
BP	GO:0042551	neuron maturation	2/52	45/18800	0.00688494	0.032912871	0.01995697	NR4A2/C3	2
BP	GO:0046427	positive regulation of receptor signaling pathway via JAK-STAT	2/52	45/18800	0.00688494	0.032912871	0.01995697	IL10RA/CCL5	2
BP	GO:1900271	regulation of long-term synaptic potentiation	2/52	45/18800	0.00688494	0.032912871	0.01995697	CX3CR1/TYROBP	2
BP	GO:0002687	positive regulation of leukocyte migration	3/52	141/18800	0.006979094	0.033264259	0.020170037	CX3CR1/CCL5/RAC2	3
BP	GO:0031640	killing of cells of another organism	2/52	46/18800	0.007185229	0.034145735	0.020704526	LTF/LYZ	2
BP	GO:0010543	regulation of platelet activation	2/52	48/18800	0.007803339	0.036865628	0.022353754	HRG/FCER1G	2
BP	GO:0033628	regulation of cell adhesion mediated by integrin	2/52	48/18800	0.007803339	0.036865628	0.022353754	HRG/CCL5	2
BP	GO:0043300	regulation of leukocyte degranulation	2/52	49/18800	0.008121093	0.038143091	0.023128353	ITGB2/RAC2	2
BP	GO:1904894	positive regulation of receptor signaling pathway via STAT	2/52	49/18800	0.008121093	0.038143091	0.023128353	IL10RA/CCL5	2
BP	GO:0006874	cellular calcium ion homeostasis	5/52	456/18800	0.008370119	0.039092679	0.023704144	CX3CR1/PTPRC/CCL5/CXCL9/KNG1	5
BP	GO:0008360	regulation of cell shape	3/52	151/18800	0.008419885	0.039092679	0.023704144	ITGB2/HCK/RAC2	3
BP	GO:0070231	T cell apoptotic process	2/52	50/18800	0.008444601	0.039092679	0.023704144	ARG2/CCL5	2
BP	GO:2000107	negative regulation of leukocyte apoptotic process	2/52	50/18800	0.008444601	0.039092679	0.023704144	ARG2/CCL5	2
BP	GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	2/52	50/18800	0.008444601	0.039092679	0.023704144	PTPRC/TNFSF10	2
BP	GO:0045778	positive regulation of ossification	2/52	51/18800	0.008773832	0.040269637	0.024417801	LTF/ISG15	2
BP	GO:0071622	regulation of granulocyte chemotaxis	2/52	51/18800	0.008773832	0.040269637	0.024417801	CCL5/RAC2	2
BP	GO:2000179	positive regulation of neural precursor cell proliferation	2/52	51/18800	0.008773832	0.040269637	0.024417801	CX3CR1/EGF	2
BP	GO:0051092	positive regulation of NF-kappaB transcription factor activity	3/52	154/18800	0.008883691	0.040658029	0.024653305	CX3CR1/LTF/S100A8	3
BP	GO:0070169	positive regulation of biomineral tissue development	2/52	52/18800	0.009108751	0.041569966	0.025206265	LTF/ISG15	2
BP	GO:0055074	calcium ion homeostasis	5/52	468/18800	0.009303028	0.04233666	0.025671156	CX3CR1/PTPRC/CCL5/CXCL9/KNG1	5
BP	GO:0031960	response to corticosteroid	3/52	157/18800	0.009362255	0.042403526	0.0257117	CYBB/SDC1/FOS	3
BP	GO:0010043	response to zinc ion	2/52	53/18800	0.009449327	0.042403526	0.0257117	VCAM1/S100A8	2
BP	GO:0048260	positive regulation of receptor-mediated endocytosis	2/52	53/18800	0.009449327	0.042403526	0.0257117	C3/EGF	2
BP	GO:0110151	positive regulation of biomineralization	2/52	53/18800	0.009449327	0.042403526	0.0257117	LTF/ISG15	2
BP	GO:1902743	regulation of lamellipodium organization	2/52	53/18800	0.009449327	0.042403526	0.0257117	HRG/RAC2	2
BP	GO:0008064	regulation of actin polymerization or depolymerization	3/52	158/18800	0.009525073	0.042506626	0.025774216	TMSB10/HCK/TMSB15A	3
BP	GO:0046631	alpha-beta T cell activation	3/52	158/18800	0.009525073	0.042506626	0.025774216	ARG2/PTPRC/HLA-DRA	3
BP	GO:0030832	regulation of actin filament length	3/52	159/18800	0.009689544	0.043121148	0.026146836	TMSB10/HCK/TMSB15A	3
BP	GO:0019932	second-messenger-mediated signaling	4/52	303/18800	0.009760002	0.043315051	0.026264411	CX3CR1/PTPRC/VCAM1/DEFB1	4
BP	GO:0051703	biological process involved in intraspecies interaction between organisms	2/52	54/18800	0.009795527	0.043353278	0.02628759	CX3CR1/LTF	2
BP	GO:0007162	negative regulation of cell adhesion	4/52	305/18800	0.009981263	0.044054287	0.026712652	HRG/ARG2/PTPRC/KNG1	4
BP	GO:0002763	positive regulation of myeloid leukocyte differentiation	2/52	55/18800	0.010147317	0.044301703	0.026862674	TYROBP/FOS	2
BP	GO:0042743	hydrogen peroxide metabolic process	2/52	55/18800	0.010147317	0.044301703	0.026862674	CYBB/RAC2	2
BP	GO:0061098	positive regulation of protein tyrosine kinase activity	2/52	55/18800	0.010147317	0.044301703	0.026862674	CCL5/EGF	2
BP	GO:1905517	macrophage migration	2/52	55/18800	0.010147317	0.044301703	0.026862674	CX3CR1/CCL5	2
BP	GO:0060337	type I interferon signaling pathway	2/52	56/18800	0.010504667	0.045737888	0.027733517	IFITM1/ISG15	2
BP	GO:0070228	regulation of lymphocyte apoptotic process	2/52	57/18800	0.010867544	0.047023198	0.028512874	ARG2/CCL5	2
BP	GO:0001959	regulation of cytokine-mediated signaling pathway	3/52	166/18800	0.010887432	0.047023198	0.028512874	PTPRC/CCL5/ISG15	3
BP	GO:1903034	regulation of response to wounding	3/52	166/18800	0.010887432	0.047023198	0.028512874	APOH/HRG/KNG1	3
BP	GO:0006584	catecholamine metabolic process	2/52	58/18800	0.011235915	0.047886398	0.029036282	NR4A2/ITGB2	2
BP	GO:0009712	catechol-containing compound metabolic process	2/52	58/18800	0.011235915	0.047886398	0.029036282	NR4A2/ITGB2	2
BP	GO:0032481	positive regulation of type I interferon production	2/52	58/18800	0.011235915	0.047886398	0.029036282	ISG15/CD14	2
BP	GO:0071357	cellular response to type I interferon	2/52	58/18800	0.011235915	0.047886398	0.029036282	IFITM1/ISG15	2
BP	GO:0090303	positive regulation of wound healing	2/52	58/18800	0.011235915	0.047886398	0.029036282	APOH/HRG	2
BP	GO:1901652	response to peptide	5/52	491/18800	0.011288392	0.04798311	0.029094924	NR4A2/CYBB/VCAM1/REG1A/GDF15	5
BP	GO:0030041	actin filament polymerization	3/52	169/18800	0.01142594	0.048439971	0.029371945	TMSB10/HCK/TMSB15A	3
BP	GO:0044089	positive regulation of cellular component biogenesis	5/52	494/18800	0.011567156	0.048706522	0.02953357	HRG/HCK/SDC1/RAC2/ISG15	5
BP	GO:0002218	activation of innate immune response	2/52	59/18800	0.011609748	0.048706522	0.02953357	HCK/TYROBP	2
BP	GO:0006826	iron ion transport	2/52	59/18800	0.011609748	0.048706522	0.02953357	HRG/LTF	2
BP	GO:0046686	response to cadmium ion	2/52	59/18800	0.011609748	0.048706522	0.02953357	CYBB/FOS	2
BP	GO:1903409	reactive oxygen species biosynthetic process	2/52	61/18800	0.012373677	0.051649733	0.031318209	CYBB/ARG2	2
BP	GO:0007204	positive regulation of cytosolic calcium ion concentration	4/52	325/18800	0.012375417	0.051649733	0.031318209	CX3CR1/PTPRC/CXCL9/KNG1	4
BP	GO:0002221	pattern recognition receptor signaling pathway	3/52	176/18800	0.012741647	0.052859469	0.032051741	LTF/CTSS/CD14	3
BP	GO:0002712	regulation of B cell mediated immunity	2/52	62/18800	0.012763708	0.052859469	0.032051741	PTPRC/C3	2
BP	GO:0002889	regulation of immunoglobulin mediated immune response	2/52	62/18800	0.012763708	0.052859469	0.032051741	PTPRC/C3	2
BP	GO:0060759	regulation of response to cytokine stimulus	3/52	178/18800	0.013132875	0.054079771	0.03279168	PTPRC/CCL5/ISG15	3
BP	GO:0032613	interleukin-10 production	2/52	63/18800	0.013159075	0.054079771	0.03279168	TYROBP/ISG15	2
BP	GO:0032653	regulation of interleukin-10 production	2/52	63/18800	0.013159075	0.054079771	0.03279168	TYROBP/ISG15	2
BP	GO:0030888	regulation of B cell proliferation	2/52	64/18800	0.013559747	0.055303173	0.033533499	PTPRC/TYROBP	2
BP	GO:0032507	maintenance of protein location in cell	2/52	64/18800	0.013559747	0.055303173	0.033533499	TMSB10/TMSB15A	2
BP	GO:0034340	response to type I interferon	2/52	64/18800	0.013559747	0.055303173	0.033533499	IFITM1/ISG15	2
BP	GO:0042113	B cell activation	4/52	336/18800	0.013836863	0.056290875	0.0341324	PTPRC/TYROBP/VCAM1/IGHM	4
BP	GO:0048469	cell maturation	3/52	183/18800	0.014140901	0.05738285	0.034794527	NR4A2/C3/DEFB1	3
BP	GO:0010517	regulation of phospholipase activity	2/52	66/18800	0.014376882	0.057758496	0.035022303	CCL5/ANGPTL3	2
BP	GO:0030837	negative regulation of actin filament polymerization	2/52	66/18800	0.014376882	0.057758496	0.035022303	TMSB10/TMSB15A	2
BP	GO:0071677	positive regulation of mononuclear cell migration	2/52	66/18800	0.014376882	0.057758496	0.035022303	CX3CR1/CCL5	2
BP	GO:2000514	regulation of CD4-positive, alpha-beta T cell activation	2/52	66/18800	0.014376882	0.057758496	0.035022303	ARG2/HLA-DRA	2
BP	GO:0002704	negative regulation of leukocyte mediated immunity	2/52	67/18800	0.014793282	0.059283526	0.035947017	CX3CR1/PTPRC	2
BP	GO:0051896	regulation of protein kinase B signaling	3/52	187/18800	0.014978268	0.059875906	0.036306211	CX3CR1/EGF/GDF15	3
BP	GO:0060193	positive regulation of lipase activity	2/52	68/18800	0.015214863	0.060671149	0.036788413	APOH/CCL5	2
BP	GO:0030336	negative regulation of cell migration	4/52	346/18800	0.015257369	0.060690423	0.0368001	CX3CR1/APOH/HRG/IFITM1	4
BP	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	3/52	190/18800	0.015624423	0.061610289	0.037357868	PTPRC/CCL5/EGF	3
BP	GO:0033344	cholesterol efflux	2/52	69/18800	0.015641594	0.061610289	0.037357868	APOM/EGF	2
BP	GO:0034394	protein localization to cell surface	2/52	69/18800	0.015641594	0.061610289	0.037357868	TYROBP/EGF	2
BP	GO:0046635	positive regulation of alpha-beta T cell activation	2/52	69/18800	0.015641594	0.061610289	0.037357868	PTPRC/HLA-DRA	2
BP	GO:0002548	monocyte chemotaxis	2/52	70/18800	0.016073445	0.063156878	0.038295653	CX3CR1/CCL5	2
BP	GO:0002695	negative regulation of leukocyte activation	3/52	193/18800	0.016286165	0.06383701	0.038708057	ARG2/PTPRC/TYROBP	3
BP	GO:0030032	lamellipodium assembly	2/52	71/18800	0.016510385	0.064402494	0.039050942	HRG/RAC2	2
BP	GO:2000379	positive regulation of reactive oxygen species metabolic process	2/52	71/18800	0.016510385	0.064402494	0.039050942	ITGB2/TYROBP	2
BP	GO:0051480	regulation of cytosolic calcium ion concentration	4/52	356/18800	0.016767281	0.065246592	0.039562767	CX3CR1/PTPRC/CXCL9/KNG1	4
BP	GO:1903036	positive regulation of response to wounding	2/52	72/18800	0.016952384	0.065807928	0.039903138	APOH/HRG	2
BP	GO:0045123	cellular extravasation	2/52	73/18800	0.017399411	0.067380893	0.040856917	CX3CR1/VCAM1	2
BP	GO:2000146	negative regulation of cell motility	4/52	361/18800	0.01755629	0.067825379	0.041126434	CX3CR1/APOH/HRG/IFITM1	4
BP	GO:0008154	actin polymerization or depolymerization	3/52	199/18800	0.017656563	0.068049577	0.041262379	TMSB10/HCK/TMSB15A	3
BP	GO:0035924	cellular response to vascular endothelial growth factor stimulus	2/52	74/18800	0.017851437	0.068299753	0.041414075	HRG/VCAM1	2
BP	GO:0045669	positive regulation of osteoblast differentiation	2/52	74/18800	0.017851437	0.068299753	0.041414075	LTF/IFITM1	2
BP	GO:0061515	myeloid cell development	2/52	74/18800	0.017851437	0.068299753	0.041414075	LTF/TYROBP	2
BP	GO:0050864	regulation of B cell activation	3/52	200/18800	0.017891059	0.068299753	0.041414075	PTPRC/TYROBP/IGHM	3
BP	GO:0032271	regulation of protein polymerization	3/52	201/18800	0.018127299	0.069038012	0.041861724	TMSB10/HCK/TMSB15A	3
BP	GO:0002437	inflammatory response to antigenic stimulus	2/52	75/18800	0.018308432	0.069236816	0.04198227	HCK/C3	2
BP	GO:0006809	nitric oxide biosynthetic process	2/52	75/18800	0.018308432	0.069236816	0.04198227	CX3CR1/ARG2	2
BP	GO:0070227	lymphocyte apoptotic process	2/52	75/18800	0.018308432	0.069236816	0.04198227	ARG2/CCL5	2
BP	GO:0002292	T cell differentiation involved in immune response	2/52	76/18800	0.018770365	0.070817468	0.04294071	FCER1G/HLA-DRA	2
BP	GO:0017157	regulation of exocytosis	3/52	204/18800	0.018846498	0.070848521	0.04295954	ITGB2/SDC1/RAC2	3
BP	GO:0051271	negative regulation of cellular component movement	4/52	369/18800	0.018866552	0.070848521	0.04295954	CX3CR1/APOH/HRG/IFITM1	4
BP	GO:0032729	positive regulation of interferon-gamma production	2/52	77/18800	0.019237208	0.072072424	0.043701662	ISG15/CD14	2
BP	GO:0043523	regulation of neuron apoptotic process	3/52	207/18800	0.019581431	0.073191846	0.044380433	CX3CR1/NR4A2/TYROBP	3
BP	GO:1903533	regulation of protein targeting	2/52	78/18800	0.01970893	0.073497886	0.044566002	ITGB2/RAC2	2
BP	GO:0030100	regulation of endocytosis	3/52	208/18800	0.019829909	0.073608257	0.044632927	C3/EGF/CD14	3
BP	GO:0071902	positive regulation of protein serine/threonine kinase activity	3/52	208/18800	0.019829909	0.073608257	0.044632927	LTF/PTPRC/EGF	3
BP	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	2/52	79/18800	0.020185503	0.074584506	0.045224883	CCL5/EGF	2
BP	GO:1903556	negative regulation of tumor necrosis factor superfamily cytokine production	2/52	79/18800	0.020185503	0.074584506	0.045224883	LTF/ARG2	2
BP	GO:0002573	myeloid leukocyte differentiation	3/52	210/18800	0.020332119	0.074954333	0.04544913	LTF/TYROBP/FOS	3
BP	GO:0034764	positive regulation of transmembrane transport	3/52	213/18800	0.021098577	0.076751379	0.046538783	CTSS/C3/CXCL9	3
BP	GO:0030098	lymphocyte differentiation	4/52	382/18800	0.021123047	0.076751379	0.046538783	FCER1G/PTPRC/VCAM1/HLA-DRA	4
BP	GO:0050878	regulation of body fluid levels	4/52	382/18800	0.021123047	0.076751379	0.046538783	APOH/HRG/FCER1G/KNG1	4
BP	GO:0030500	regulation of bone mineralization	2/52	81/18800	0.02115308	0.076751379	0.046538783	LTF/ISG15	2
BP	GO:0032272	negative regulation of protein polymerization	2/52	81/18800	0.02115308	0.076751379	0.046538783	TMSB10/TMSB15A	2
BP	GO:0045445	myoblast differentiation	2/52	81/18800	0.02115308	0.076751379	0.046538783	SDC1/CXCL9	2
BP	GO:0046209	nitric oxide metabolic process	2/52	81/18800	0.02115308	0.076751379	0.046538783	CX3CR1/ARG2	2
BP	GO:2001057	reactive nitrogen species metabolic process	2/52	82/18800	0.021644027	0.078356243	0.047511904	CX3CR1/ARG2	2
BP	GO:0050866	negative regulation of cell activation	3/52	216/18800	0.021880819	0.079035871	0.047924002	ARG2/PTPRC/TYROBP	3
BP	GO:0045921	positive regulation of exocytosis	2/52	83/18800	0.022139708	0.079613994	0.048274551	ITGB2/SDC1	2
BP	GO:0060395	SMAD protein signal transduction	2/52	83/18800	0.022139708	0.079613994	0.048274551	FOS/GDF15	2
BP	GO:0002685	regulation of leukocyte migration	3/52	218/18800	0.022411086	0.080410376	0.048757443	CX3CR1/CCL5/RAC2	3
BP	GO:0050672	negative regulation of lymphocyte proliferation	2/52	84/18800	0.022640093	0.081051533	0.049146214	ARG2/TYROBP	2
BP	GO:0030099	myeloid cell differentiation	4/52	391/18800	0.022778898	0.081367639	0.049337887	LTF/TYROBP/ISG15/FOS	4
BP	GO:0032945	negative regulation of mononuclear cell proliferation	2/52	85/18800	0.023145154	0.08212961	0.049799914	ARG2/TYROBP	2
BP	GO:2000106	regulation of leukocyte apoptotic process	2/52	85/18800	0.023145154	0.08212961	0.049799914	ARG2/CCL5	2
BP	GO:2000177	regulation of neural precursor cell proliferation	2/52	85/18800	0.023145154	0.08212961	0.049799914	CX3CR1/EGF	2
CC	GO:0034774	secretory granule lumen	10/52	322/19594	1.07E-08	5.71E-07	3.09E-07	APOH/HRG/LTF/ALB/C3/LYZ/EGF/KNG1/SERPINA3/S100A8	10
CC	GO:0060205	cytoplasmic vesicle lumen	10/52	325/19594	1.17E-08	5.71E-07	3.09E-07	APOH/HRG/LTF/ALB/C3/LYZ/EGF/KNG1/SERPINA3/S100A8	10
CC	GO:0031983	vesicle lumen	10/52	327/19594	1.24E-08	5.71E-07	3.09E-07	APOH/HRG/LTF/ALB/C3/LYZ/EGF/KNG1/SERPINA3/S100A8	10
CC	GO:0009897	external side of plasma membrane	11/52	455/19594	2.40E-08	8.29E-07	4.49E-07	CX3CR1/FCER1G/ITGB2/AZGP1/CD48/PTPRC/SDC1/VCAM1/CXCL9/CD14/IGHM	11
CC	GO:0042613	MHC class II protein complex	4/52	17/19594	1.02E-07	2.82E-06	1.53E-06	HLA-DMB/HLA-DMA/HLA-DQB1/HLA-DRA	4
CC	GO:0062023	collagen-containing extracellular matrix	10/52	429/19594	1.59E-07	3.65E-06	1.98E-06	APOH/HRG/CTSS/AZGP1/TNC/KNG1/SERPINA3/ANGPTL3/GDF15/S100A8	10
CC	GO:0042611	MHC protein complex	4/52	25/19594	5.35E-07	1.06E-05	5.72E-06	HLA-DMB/HLA-DMA/HLA-DQB1/HLA-DRA	4
CC	GO:0031093	platelet alpha granule lumen	5/52	67/19594	9.22E-07	1.59E-05	8.61E-06	HRG/ALB/EGF/KNG1/SERPINA3	5
CC	GO:0072562	blood microparticle	6/52	147/19594	2.47E-06	3.78E-05	2.05E-05	HRG/ALB/C3/KNG1/SERPINA3/IGHM	6
CC	GO:0031091	platelet alpha granule	5/52	91/19594	4.23E-06	5.83E-05	3.16E-05	HRG/ALB/EGF/KNG1/SERPINA3	5
CC	GO:0070820	tertiary granule	6/52	164/19594	4.64E-06	5.83E-05	3.16E-05	LTF/FCER1G/CTSS/CYBB/ITGB2/LYZ	6
CC	GO:0030139	endocytic vesicle	7/52	342/19594	3.16E-05	0.000363678	0.000196958	LTF/CTSS/CYBB/RAC2/EGF/HLA-DQB1/HLA-DRA	7
CC	GO:0005775	vacuolar lumen	5/52	174/19594	9.67E-05	0.001026133	0.000555724	CTSS/SDC1/C3/LYZ/SERPINA3	5
CC	GO:0030666	endocytic vesicle membrane	5/52	194/19594	0.000160995	0.00157133	0.000850987	CYBB/RAC2/EGF/HLA-DQB1/HLA-DRA	5
CC	GO:0030667	secretory granule membrane	6/52	312/19594	0.000170797	0.00157133	0.000850987	FCER1G/CYBB/ITGB2/PTPRC/TYROBP/CD14	6
CC	GO:1904724	tertiary granule lumen	3/52	55/19594	0.000419577	0.003618851	0.001959866	LTF/CTSS/LYZ	3
CC	GO:0045335	phagocytic vesicle	4/52	138/19594	0.000490649	0.003982915	0.002157033	LTF/CTSS/CYBB/RAC2	4
CC	GO:0005765	lysosomal membrane	6/52	404/19594	0.000676364	0.00491254	0.002660491	HLA-DMB/IFITM1/HLA-DMA/EGF/HLA-DQB1/HLA-DRA	6
CC	GO:0098852	lytic vacuole membrane	6/52	404/19594	0.000676364	0.00491254	0.002660491	HLA-DMB/IFITM1/HLA-DMA/EGF/HLA-DQB1/HLA-DRA	6
CC	GO:0042581	specific granule	4/52	160/19594	0.000854559	0.005896454	0.00319335	LTF/CYBB/ITGB2/LYZ	4
CC	GO:0030669	clathrin-coated endocytic vesicle membrane	3/52	72/19594	0.000924013	0.006033211	0.003267414	EGF/HLA-DQB1/HLA-DRA	3
CC	GO:0070821	tertiary granule membrane	3/52	73/19594	0.000961816	0.006033211	0.003267414	FCER1G/CYBB/ITGB2	3
CC	GO:0005774	vacuolar membrane	6/52	449/19594	0.001168588	0.007011525	0.003797241	HLA-DMB/IFITM1/HLA-DMA/EGF/HLA-DQB1/HLA-DRA	6
CC	GO:0034361	very-low-density lipoprotein particle	2/52	20/19594	0.00127295	0.007026686	0.003805451	APOH/APOM	2
CC	GO:0034385	triglyceride-rich plasma lipoprotein particle	2/52	20/19594	0.00127295	0.007026686	0.003805451	APOH/APOM	2
CC	GO:0045121	membrane raft	5/52	326/19594	0.001693785	0.008644827	0.00468179	ITGB2/CD48/PTPRC/HCK/CD14	5
CC	GO:0098857	membrane microdomain	5/52	327/19594	0.001716668	0.008644827	0.00468179	ITGB2/CD48/PTPRC/HCK/CD14	5
CC	GO:0035578	azurophil granule lumen	3/52	91/19594	0.001816666	0.008644827	0.00468179	C3/LYZ/SERPINA3	3
CC	GO:0045334	clathrin-coated endocytic vesicle	3/52	91/19594	0.001816666	0.008644827	0.00468179	EGF/HLA-DQB1/HLA-DRA	3
CC	GO:0034364	high-density lipoprotein particle	2/52	27/19594	0.002323846	0.010689693	0.005789231	APOH/APOM	2
CC	GO:0036019	endolysosome	2/52	28/19594	0.002498365	0.011121752	0.006023222	HRG/CTSS	2
CC	GO:0071556	integral component of lumenal side of endoplasmic reticulum membrane	2/52	29/19594	0.002678884	0.011202606	0.00606701	HLA-DQB1/HLA-DRA	2
CC	GO:0098553	lumenal side of endoplasmic reticulum membrane	2/52	29/19594	0.002678884	0.011202606	0.00606701	HLA-DQB1/HLA-DRA	2
CC	GO:0030665	clathrin-coated vesicle membrane	3/52	111/19594	0.003195765	0.012971047	0.007024747	EGF/HLA-DQB1/HLA-DRA	3
CC	GO:0098576	lumenal side of membrane	2/52	35/19594	0.003886251	0.015321332	0.008297594	HLA-DQB1/HLA-DRA	2
CC	GO:0034358	plasma lipoprotein particle	2/52	36/19594	0.004107893	0.015321332	0.008297594	APOH/APOM	2
CC	GO:1990777	lipoprotein particle	2/52	36/19594	0.004107893	0.015321332	0.008297594	APOH/APOM	2
CC	GO:0032994	protein-lipid complex	2/52	39/19594	0.004807198	0.017457717	0.009454599	APOH/APOM	2
CC	GO:0005925	focal adhesion	5/52	419/19594	0.00497251	0.017595036	0.009528967	ITGB2/PTPRC/HCK/RAC2/TNC	5
CC	GO:0030055	cell-substrate junction	5/52	428/19594	0.005434869	0.018750299	0.010154624	ITGB2/PTPRC/HCK/RAC2/TNC	5
CC	GO:0005770	late endosome	4/52	283/19594	0.006695425	0.02253582	0.012204754	HLA-DMB/CTSS/HLA-DMA/HLA-DRA	4
CC	GO:0031902	late endosome membrane	3/52	152/19594	0.00766115	0.02517235	0.013632623	HLA-DMB/HLA-DMA/HLA-DRA	3
CC	GO:0005766	primary lysosome	3/52	155/19594	0.008081887	0.025347737	0.013727608	C3/LYZ/SERPINA3	3
CC	GO:0042582	azurophil granule	3/52	155/19594	0.008081887	0.025347737	0.013727608	C3/LYZ/SERPINA3	3
CC	GO:0005788	endoplasmic reticulum lumen	4/52	311/19594	0.009267796	0.02842124	0.015392128	ALB/C3/TNC/KNG1	4
CC	GO:0030662	coated vesicle membrane	3/52	176/19594	0.011407649	0.033234115	0.017998643	EGF/HLA-DQB1/HLA-DRA	3
CC	GO:0101003	ficolin-1-rich granule membrane	2/52	61/19594	0.011439115	0.033234115	0.017998643	FCER1G/ITGB2	2
CC	GO:0012507	ER to Golgi transport vesicle membrane	2/52	62/19594	0.011800519	0.033234115	0.017998643	HLA-DQB1/HLA-DRA	2
CC	GO:0035580	specific granule lumen	2/52	62/19594	0.011800519	0.033234115	0.017998643	LTF/LYZ	2
CC	GO:0101002	ficolin-1-rich granule	3/52	185/19594	0.013041164	0.035993612	0.019493108	FCER1G/CTSS/ITGB2	3
CC	GO:0030136	clathrin-coated vesicle	3/52	192/19594	0.014399668	0.038963808	0.021101681	EGF/HLA-DQB1/HLA-DRA	3
CC	GO:0030670	phagocytic vesicle membrane	2/52	77/19594	0.01780425	0.047249739	0.025589104	CYBB/RAC2	2
CC	GO:0005769	early endosome	4/52	389/19594	0.019591462	0.051011732	0.027626491	LTF/VCAM1/HLA-DRA/ANGPTL3	4
CC	GO:0035579	specific granule membrane	2/52	91/19594	0.024338912	0.062199442	0.033685434	CYBB/ITGB2	2
CC	GO:0030134	COPII-coated ER to Golgi transport vesicle	2/52	94/19594	0.025849096	0.064857733	0.035125088	HLA-DQB1/HLA-DRA	2
CC	GO:0043202	lysosomal lumen	2/52	97/19594	0.027396562	0.067512957	0.036563081	CTSS/SDC1	2
CC	GO:0005614	interstitial matrix	1/52	11/19594	0.028815567	0.06778524	0.036710542	TNC	1
CC	GO:0019774	proteasome core complex, beta-subunit complex	1/52	11/19594	0.028815567	0.06778524	0.036710542	PSMB8	1
CC	GO:0032588	trans-Golgi network membrane	2/52	100/19594	0.028980646	0.06778524	0.036710542	HLA-DQB1/HLA-DRA	2
CC	GO:0005796	Golgi lumen	2/52	104/19594	0.031148589	0.071023431	0.038464254	SDC1/DEFB1	2
CC	GO:0034362	low-density lipoprotein particle	1/52	12/19594	0.031394415	0.071023431	0.038464254	APOM	1
CC	GO:0042627	chylomicron	1/52	13/19594	0.033966547	0.07560296	0.040944395	APOH	1
CC	GO:0005884	actin filament	2/52	113/19594	0.036252331	0.07638505	0.041367952	HCK/RAC2	2
CC	GO:0044853	plasma membrane raft	2/52	113/19594	0.036252331	0.07638505	0.041367952	ITGB2/HCK	2
CC	GO:0031089	platelet dense granule lumen	1/52	14/19594	0.03653198	0.07638505	0.041367952	APOH	1
CC	GO:0043020	NADPH oxidase complex	1/52	14/19594	0.03653198	0.07638505	0.041367952	CYBB	1
CC	GO:0030135	coated vesicle	3/52	290/19594	0.04166945	0.085826629	0.046481241	EGF/HLA-DQB1/HLA-DRA	3
MF	GO:0005539	glycosaminoglycan binding	9/52	234/18410	1.70E-08	3.52E-06	2.40E-06	APOH/HRG/LTF/CXCL6/PTPRC/REG1A/KNG1/ANGPTL3/IGHM	9
MF	GO:0042379	chemokine receptor binding	6/52	71/18410	4.69E-08	4.86E-06	3.31E-06	CX3CR1/CXCL6/CCL5/CXCL9/DEFB1/CXCL14	6
MF	GO:0008201	heparin binding	7/52	168/18410	4.40E-07	3.04E-05	2.07E-05	APOH/HRG/LTF/CXCL6/PTPRC/KNG1/ANGPTL3	7
MF	GO:0048018	receptor ligand activity	10/52	489/18410	9.27E-07	3.64E-05	2.48E-05	CXCL6/CCL5/TNFSF10/EGF/REG1A/CXCL9/IL32/CXCL14/ANGPTL3/GDF15	10
MF	GO:0023026	MHC class II protein complex binding	4/52	27/18410	9.46E-07	3.64E-05	2.48E-05	HLA-DMB/HLA-DMA/HLA-DQB1/HLA-DRA	4
MF	GO:0030546	signaling receptor activator activity	10/52	496/18410	1.05E-06	3.64E-05	2.48E-05	CXCL6/CCL5/TNFSF10/EGF/REG1A/CXCL9/IL32/CXCL14/ANGPTL3/GDF15	10
MF	GO:0023023	MHC protein complex binding	4/52	36/18410	3.12E-06	8.07E-05	5.50E-05	HLA-DMB/HLA-DMA/HLA-DQB1/HLA-DRA	4
MF	GO:0043394	proteoglycan binding	4/52	36/18410	3.12E-06	8.07E-05	5.50E-05	HRG/CTSS/PTPRC/TNC	4
MF	GO:0005125	cytokine activity	7/52	235/18410	4.14E-06	9.53E-05	6.49E-05	CXCL6/CCL5/TNFSF10/CXCL9/IL32/CXCL14/GDF15	7
MF	GO:1901681	sulfur compound binding	7/52	267/18410	9.56E-06	0.000188261	0.000128284	APOH/HRG/LTF/CXCL6/PTPRC/KNG1/ANGPTL3	7
MF	GO:0005126	cytokine receptor binding	7/52	272/18410	1.08E-05	0.000188261	0.000128284	CX3CR1/CXCL6/CCL5/TNFSF10/CXCL9/DEFB1/CXCL14	7
MF	GO:0008009	chemokine activity	4/52	49/18410	1.09E-05	0.000188261	0.000128284	CXCL6/CCL5/CXCL9/CXCL14	4
MF	GO:0001664	G protein-coupled receptor binding	7/52	288/18410	1.56E-05	0.000248622	0.000169414	CX3CR1/CXCL6/CCL5/C3/CXCL9/DEFB1/CXCL14	7
MF	GO:0140375	immune receptor activity	5/52	148/18410	6.02E-05	0.000889451	0.000606084	CX3CR1/FCER1G/IL10RA/HLA-DQB1/HLA-DRA	5
MF	GO:0004866	endopeptidase inhibitor activity	5/52	180/18410	0.000151399	0.002089312	0.001423686	HRG/LTF/C3/KNG1/SERPINA3	5
MF	GO:0030414	peptidase inhibitor activity	5/52	187/18410	0.000180897	0.002340359	0.001594753	HRG/LTF/C3/KNG1/SERPINA3	5
MF	GO:0061135	endopeptidase regulator activity	5/52	194/18410	0.0002146	0.002613068	0.00178058	HRG/LTF/C3/KNG1/SERPINA3	5
MF	GO:0032395	MHC class II receptor activity	2/52	10/18410	0.000347064	0.003991231	0.00271968	HLA-DQB1/HLA-DRA	2
MF	GO:0061134	peptidase regulator activity	5/52	230/18410	0.000469498	0.00511506	0.003485472	HRG/LTF/C3/KNG1/SERPINA3	5
MF	GO:0004869	cysteine-type endopeptidase inhibitor activity	3/52	56/18410	0.000530096	0.005486492	0.003738571	HRG/LTF/KNG1	3
MF	GO:0004857	enzyme inhibitor activity	6/52	390/18410	0.000777591	0.007664829	0.005222919	HRG/LTF/C3/KNG1/SERPINA3/ANGPTL3	6
MF	GO:0060229	lipase activator activity	2/52	16/18410	0.000915512	0.00861414	0.005869793	APOH/CCL5	2
MF	GO:0005178	integrin binding	4/52	156/18410	0.000978867	0.008809807	0.006003123	ITGB2/ISG15/VCAM1/ANGPTL3	4
MF	GO:0008083	growth factor activity	4/52	162/18410	0.001125927	0.008916841	0.006076057	EGF/REG1A/ANGPTL3/GDF15	4
MF	GO:0042834	peptidoglycan binding	2/52	18/18410	0.001163066	0.008916841	0.006076057	REG1A/IGHM	2
MF	GO:0043395	heparan sulfate proteoglycan binding	2/52	18/18410	0.001163066	0.008916841	0.006076057	HRG/PTPRC	2
MF	GO:0045236	CXCR chemokine receptor binding	2/52	18/18410	0.001163066	0.008916841	0.006076057	CXCL6/CXCL9	2
MF	GO:0030296	protein tyrosine kinase activator activity	2/52	20/18410	0.001439121	0.010460279	0.007127777	CCL5/EGF	2
MF	GO:0003823	antigen binding	4/52	174/18410	0.00146545	0.010460279	0.007127777	CD48/HLA-DQB1/HLA-DRA/IGHM	4
MF	GO:0019865	immunoglobulin binding	2/52	24/18410	0.002075466	0.014320715	0.009758331	HRG/FCER1G	2
MF	GO:0019887	protein kinase regulator activity	4/52	207/18410	0.002756793	0.018408263	0.012543642	LTF/CCL5/RAC2/EGF	4
MF	GO:0003785	actin monomer binding	2/52	29/18410	0.003025622	0.01957199	0.013336622	TMSB10/TMSB15A	2
MF	GO:0030295	protein kinase activator activity	3/52	104/18410	0.003166043	0.019859723	0.013532687	LTF/CCL5/EGF	3
MF	GO:0019209	kinase activator activity	3/52	110/18410	0.003707936	0.022574785	0.015382767	LTF/CCL5/EGF	3
MF	GO:0001530	lipopolysaccharide binding	2/52	34/18410	0.004143213	0.024504143	0.016697458	LTF/CD14	2
MF	GO:0019207	kinase regulator activity	4/52	235/18410	0.00433689	0.024937119	0.016992494	LTF/CCL5/RAC2/EGF	4
MF	GO:0042605	peptide antigen binding	2/52	37/18410	0.004892173	0.027369727	0.018650106	HLA-DQB1/HLA-DRA	2
MF	GO:0048020	CCR chemokine receptor binding	2/52	47/18410	0.00779903	0.042484189	0.028949307	CCL5/DEFB1	2
MF	GO:0005504	fatty acid binding	2/52	49/18410	0.008453985	0.044871151	0.030575816	ALB/S100A8	2
MF	GO:0042277	peptide binding	4/52	322/18410	0.012868302	0.066593461	0.045377696	ITGB2/HLA-DQB1/HLA-DRA/CD14	4